Genetic Determinants of Steroid Responsiveness in IgA Nephropathy
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000000977 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Lin-Lin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease,…. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Glucocorticoids, Cytidine Deaminase, Methylprednisolone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National High Level Hospital Clinical Research Funding (Interdisciplinary Clinical Research Project of Peking University First Hospital), National Key Research and Development Program of China, Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Key Points Genetic variant rs477155 near cytidine deaminase identified IgA nephropathy patients with enhanced glucocorticoid response. rs477155 may regulate cytidine deaminase via glucocorticoid receptor, linking genomic variation to steroid sensitivity and individualized treatment optimization.
Background
Glucocorticoid therapy improves outcomes in high-risk IgA nephropathy but shows variable efficacy and adverse effects, potentially influenced by genetic factors.
Methods
We conducted a genome-wide pharmacogenomic analysis in 260 biopsy-confirmed patients with IgA nephropathy from the Chinese The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) study cohort (134 received methylprednisolone and 126 received placebo), assessing the percentage reduction in 24-hour proteinuria at 6 months via genotype-by-treatment interaction models. Replication was performed in an independent cohort of 211 high-risk patients receiving glucocorticoid monotherapy. Functional annotation, expression quantitative trait loci mapping, regulatory analyses, and dual-luciferase reporter assays elucidated the biologic relevance of candidate loci.
Results
Genome-wide analysis identified three loci with suggestive genotype-by-treatment interaction ( P < 5.00×10 −6 ), of which rs477155 (chromosome 1, intronic to cytidine deaminase [ CDA ]) was replicated in the independent cohort (discovery P = 2.70×10 −6 , replication P = 0.01). In the TESTING study cohort, carriers of the rs477155 GG genotype had significantly higher rates of complete proteinuria remission (odds ratio, 2.5; 95% confidence interval, 1.3 to 4.9; P = 5.00×10 −3 ) and composite clinical remission (odds ratio, 2.8; 95% confidence interval, 1.6 to 4.9; P = 3.13×10 −4 ) at 6 months. Functional analyses revealed that rs477155 acts as a Cis -expression quantitative trait locus for CDA in blood and immune cells and is located within an enhancer region marked by H3K4Me1/H3K27Ac and a glucocorticoid receptor (nuclear receptor subfamily 3 group C member 1 [NR3C1])–binding site. Bioinformatics, dual-luciferase reporter assay, and RNA-seq analyses indicated that NR3C1 may directly regulate CDA expression, with rapid upregulation of CDA observed in blood after dexamethasone stimulation (9.84±0.52 versus 10.50±0.55, P = 7.41×10 −23 ). Phenome-wide association studies further linked rs477155 and CDA to a spectrum of immune and kidney traits, including acute tubulointerstitial nephritis ( P = 7.4×10 −11 ), nephritic syndrome ( P = 2.7×10 −8 ), asthma ( P = 2.5×10 −21 ), and rheumatoid arthritis ( P = 2.1×10 −12 ).
Conclusions
In this study, rs477155 was suggestively associated with glucocorticoid responsiveness in IgA nephropathy, potentially via a suggested NR3C1-regulated CDA pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Peking University First Hospital, Kidney Genetics Center, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease…
- Department of Medical Genetics, School of Basic Medical Sciences, Peking University, Beijing, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Lin-Lin Xu, Wenjian Bi, Peipei Zhang, Su-Fang Shi, Li-Jun Liu, Hong Zhang
Förderung
- National High Level Hospital Clinical Research Funding (Interdisciplinary Clinical Research Project of Peking University First Hospital)
- National Key Research and Development Program of China
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Xu, L. L., Zhou, X. J., Bi, W., Zhang, P., Shi, S. F., Liu, L. J., Lv, J. C., & Zhang, H. (2026). Genetic Determinants of Steroid Responsiveness in IgA Nephropathy. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000977
Vancouver
Xu LL, Zhou XJ, Bi W, Zhang P, Shi SF, Liu LJ, et al. Genetic Determinants of Steroid Responsiveness in IgA Nephropathy. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000000977
BibTeX
@article{Xu2026,
author = {Xu, Lin-Lin and Zhou, Xu-Jie and Bi, Wenjian and Zhang, Peipei and Shi, Su-Fang and Liu, Li-Jun and Lv, Ji-Cheng and Zhang, Hong},
title = {Genetic Determinants of Steroid Responsiveness in IgA Nephropathy},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000000977}
}
EUVIMED